METHOD FOR PREDICTING OUTCOME OF ACUTE PERIOD OF ISCHEMIC STROKE ASSOCIATED WITH COVID-19 Russian patent published in 2022 - IPC A61B5/16 G01N33/62 G01N33/68 

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely to neurology, and can be used to predict the outcome of the acute period of ischemic stroke in patients with laboratory-confirmed coronavirus infection COVID-19. Determination of the content of C-reactive protein in venous blood, the severity of the patient's condition according to the stroke scale of the National Institute of Health NIHSS is carried out. Additionally, the content of urea in the venous blood is determined. The calculation of the forecast of the outcome is carried out according to the formula, which includes a constant: , where: P is the probability of death, %, e is the base of the natural logarithm, a constant equal to 2.72, z is the degree of inverse logarithm, Х_сRP is the content of C-reactive protein, mg/l, X_nihss is the National Institute of Health Stroke Scale NIHSS, X_urea - urea content, mmol/l. With a P value of 35% and above, a high risk of death is predicted, below 35% - a low risk.

EFFECT: method makes it possible to simplify and improve the accuracy of predicting the outcome of the acute period of ischemic stroke in patients with COVID-19 through the use of routine techniques, as well as high sensitivity and specificity in relation to patients with COVID-19.

1 cl, 1 dwg, 3 tbl, 5 ex